Ghana Adsorbs Hydroxyurea Sickle Cell Therapy Under NHIS
Ghana has decided to absorb the cost of hydroxyurea, a modifying therapy for sickle cell patients under the National Health Insurance Scheme (NHIS).
Hydroxyurea is a treatment!-->!-->!-->…
Read More...
Read More...

